T. Rowe Price Associates »

Lucid Diagnostics shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Lucid Diagnostics (LUCD) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Lucid Diagnostics

Tip: Access up to 7 years of quarterly data

All positions including Lucid Diagnostics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lucid Diagnostics by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2026-03-31 $86k 74k 1.16
2025-12-31 $39k 35k 1.11
2025-09-30 $36k 35k 1.02
2025-06-30 $41k 35k 1.17

More positions owned by T. Rowe Price Associates

Nvidia Corporation Comm Stk (NVDA)
Apple Comm Stk (AAPL)
Microsoft Corp Comm Stk (MSFT)
Broadcom Comm Stk (AVGO)
Amazon Comm Stk (AMZN)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Visa Comm Stk (V)
Netflix Comm Stk (NFLX)
Mastercard Incorporated Comm Stk (MA)
Tesla Comm Stk (TSLA)
Jpmorgan Chase & Co Comm Stk (JPM)
Ge Aerospace Comm Stk (GE)

View all positions for T. Rowe Price Associates

Top funds holding Lucid Diagnostics

BlackRock
Vanguard Capital Management
Masters Capital Mgmt
Standard Life Aberdeen
Two Seas Capital
Geode Capital Management
Russell Investments
State Street Corporation
Wells Fargo & Company
Perkins Capital Management
Sunbelt Securities
Northern Trust
Vanguard Fiduciary Trust
Vanguard Portfolio Management
Raymond James Financial

View all funds holding Lucid Diagnostics